SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

SunTrust Robinson Humphrey Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $22

SunTrust Robinson Humphrey maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $26 to $22.

Benzinga · 05/07/2020 15:24

SunTrust Robinson Humphrey maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $26 to $22.